Cardinal Health annual research report examines milestone year in biosimilars
Go back to Cardinal Health annual research report examines milestone year in biosimilars| Cardinal Health Inc. (NYSE: CAH) | Delayed: 236.75 -3.25 (1.35%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $240.00 | 52 Week High | $91.22 | |||
| Open | $241.27 | 52 Week Low | $62.70 | |||
| Day High | $242.12 | P/E | 221.26 | |||
| Day Low | $236.33 | EPS | $1.07 | |||
| Volume | 382,282 | |||||

